Alla studier
RekryteringOBSERVATIONELL

Giessen Pulmonary Hypertension in Lung Cancer Registry

This study, called the Giessen Pulmonary Hypertension in Lung Cancer Registry, aims to understand how common a condition called pulmonary hypertension is in people who have lung cancer. Pulmonary hypertension is when there's high blood pressure in the arteries that carry blood from your heart to your lungs. Doctors at Giessen University Hospital will collect information from all their lung cancer patients as part of their regular care. They want to see if there's a link between lung cancer and pulmonary hypertension. This is an observational study, which means no special treatments or tests will be given; doctors will simply use information they already gather during normal treatment. The goal is to learn more about this connection to help future patients.

Överblick

Status
Rekrytering
Sponsor
Universitetet i Giessen
Inskrivningsmål
500
Starta
29 Jun 2020
Beräknad slutförande
29 Jan 2040

Vad handlar denna studie om?

Doctors at Giessen University Hospital are running a study to learn more about lung cancer and a condition called pulmonary hypertension. Pulmonary hypertension means that the blood pressure in the special arteries that go from your heart to your lungs is too high. This can make your heart work harder and can sometimes cause breathlessness. The aim of this study is to see how often people with lung cancer also have pulmonary hypertension.

To do this, the research team will collect information from adult patients who are already being treated for lung cancer at their hospital. They'll look at routine health information that doctors already gather during your regular check-ups and treatments. They are not asking you to do any extra tests, appointments, or take new medicines. Everything will be based on your usual care.

This study is important because understanding if pulmonary hypertension commonly affects people with lung cancer could help doctors spot it earlier or manage care better in the future. By gathering this information, they hope to build a clearer picture of how these conditions might be connected and ultimately improve the health and well-being of lung cancer patients.

Viktiga punkter

  • This study looks at how often high blood pressure in the lungs (pulmonary hypertension) occurs in people with lung cancer.
  • It's a registry study, meaning doctors will collect information from existing patient records.
  • No extra tests, appointments, or treatments are involved.
  • Only adult lung cancer patients receiving care at Giessen University Hospital are included.
  • The aim is to improve understanding and potentially future care for lung cancer patients.
  • Your medical care will not be affected by participating.

Vem kan vara berättigad?

To be part of this study, you need to be an adult patient (aged 18 or older) who is currently receiving treatment for lung cancer at the University of Giessen Lung Cancer Center.

There are no specific reasons why someone would be excluded from participating, as long as they meet the main requirement of being a lung cancer patient at this particular hospital.

Kan denna studie passa dig?

Svara på dessa snabba frågor för att se om du kan vara berättigad. Detta är endast en vägledning — forskarteamet fattar det slutgiltiga beslutet.

  1. Är jag 18 år gammal eller äldre?
  2. Do I have lung cancer?
  3. Am I being treated for lung cancer at the University of Giessen Lung Cancer Center?
  4. Do I understand that no extra tests or treatments are involved?
Svara på varje fråga för att se ditt resultat.

Vad innebär deltagande?

If you are a lung cancer patient at Giessen University Hospital and decide to take part in this registry study, you won't need to do anything extra. There are no additional visits, special tests, or new medications involved. The study will simply use information that your doctors already collect during your regular course of treatment for lung cancer. This means your care will stay exactly the same, whether you participate or not. The researchers will look at your existing medical records to understand more about pulmonary hypertension in lung cancer patients.

Potentiella risker och fördelar

Since this study only involves looking at information from your existing medical records, there are no direct physical risks to you. Your personal information will be kept private and handled carefully. The main benefit is that your information, combined with that of many other patients, could help doctors learn more about how lung cancer and pulmonary hypertension are linked. This knowledge could lead to better understanding and possibly better care for future patients. You are always free to decide not to have your information used in this study without it affecting your medical care in any way.

Platser (1)

  • University hospital Giessen
    Verifierat postnummer
    Giessen, Tyskland· Rekrytering

Vanliga frågor

What is pulmonary hypertension?

Pulmonary hypertension means you have high blood pressure in the arteries that carry blood from your heart to your lungs.

Kommer jag att behöva ta ny medicin?

No, this study doesn't involve any new medicines, treatments, or extra tests. Your care will be exactly as it is now.

Will this study change my lung cancer treatment?

No, this study is about collecting information; it will not change your current lung cancer treatment or care plan at all.

Vem kan delta i denna studie?

Adult patients (18 and older) who are being treated for lung cancer at Giessen University Hospital can be included.

Kommer min information att hållas privat?

Yes, all your health information used in this study will be kept confidential and handled securely.

Hur du får reda på mer

Bastian Eul, MD

Prata alltid med din läkare eller specialist innan du bestämmer dig för att delta i en studie.

Intresserad av att delta?

Registrera ditt intresse

Dela dina uppgifter och forskarteamet för "Giessen Pulmonary Hypertension in Lung Cancer Registry…" kommer att kontakta dig om du kan vara berättigad. Prata alltid med din läkare innan du går med på att delta.

Diskussion

Gemenskapsdiskussion

Drivs av vårt forum på community.patient.info. Var vänlig och respektfull — detta är inte medicinsk rådgivning.